About Sigachi Laboratories Limited
Sigachi Laboratories Limited is a Healthcare company based in Hyderabad (India). Manufacture of bulk drugs and drug intermediates in Telangana. Its Indian entity Sigachi Laboratories Limited reported revenue of ₹3.78 Cr. Sigachi Laboratories Limited offers products and services including Bulk Drugs and Drug Intermediates. Its focus areas include Pharmaceuticals, Drug Manufacturing, Bulk Drugs and Drug Intermediates.
Company details
Sigachi Laboratories Limited is primarily involved in the manufacture of bulk drugs and drug intermediates, which are essential components in the pharmaceutical industry. The companys operations are conducted from its registered office in Bonthapally and corporate office in Hyderabad, Telangana, India. Compliance with SEBI regulations is maintained through disclosures of annual reports, financial results, and corporate governance policies. Investor information, including share holding patterns and contact details of key personnel, is regularly updated and made available. The entity ensures adherence to legal standards as outlined in its CIN: L24230TG1994PLC018786, supporting ongoing activities in drug production.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Website slllab.com
- Legal Name Sigachi Laboratories Limited
- Date of Incorporation 21 Nov, 1994
- Jurisdiction Telangana, India
- Annual Revenue₹3.78 Cr
FY 2025 · -13% YoY
- Net Profit₹1.19 Cr
FY 2025 · 31% margin
- EBITDA₹1.75 Cr
FY 2025 · 46% margin
Associated legal entities of Sigachi Laboratories Limited
Sigachi Laboratories Limited operates through Sigachi Laboratories Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sigachi Laboratories Limited Listed CIN L24230TG1994PLC018786 | Active | 21 Nov 1994 | ₹3.8 Cr | 9 | View details |
Products & Services of Sigachi Laboratories Limited
Sigachi Laboratories Limited offers a comprehensive portfolio of products and services, including Bulk Drugs and Drug Intermediates.
Bulk drugs are manufactured for use in medicinal applications within the pharmaceutical industry
Drug intermediates are produced as precursors for bulk drugs in the pharmaceutical sector
Board of directors of Sigachi Laboratories Limited (Sigachi Laboratories Limited)
Sigachi Laboratories Limited is the primary company behind Sigachi Laboratories Limited. The board of Sigachi Laboratories Limited currently have 7 directors; the longest-serving is Adinarayana Tunuguntla, appointed in 2008. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Adinarayana Tunuguntla DIN 00917498 | Director | 01 Jul 2008 | 18 yrs 4 mo | Sigachi Laboratories Limited |
| Rajasekhar Tunuguntla DIN 02943146 | Whole-time director | 30 Jan 2010 | 16 yrs 9 mo | Sigachi Laboratories Limited |
| Mohanrao Gurram DIN 08535558 | Director | 27 Sep 2019 | 7 yrs 1 mo | Sigachi Laboratories Limited |
| Shilpa Bung DIN 08257931 | Director | 10 Feb 2021 | 5 yrs 8 mo | Sigachi Laboratories Limited |
| Sridevi Madati DIN 02446610 | Director | 24 Sep 2021 | 5 yrs 1 mo | Sigachi Laboratories Limited |
| China Sai Babu Puppala DIN 10275666 | Director | 27 Sep 2023 | 3 yrs 1 mo | Sigachi Laboratories Limited |
| Govindarajula Venkata Narasimha Rao DIN 02391404 | Director | 27 Sep 2025 | 1 yr 1 mo | Sigachi Laboratories Limited |
Financials of Sigachi Laboratories Limited
Figures of Sigachi Laboratories Limited, the primary company behind Sigachi Laboratories Limited, for FY 2025. Revenue was ₹3.78 Cr (-13% year on year). Net profit was ₹1.19 Cr (31% margin). EBITDA was ₹1.75 Cr (46% margin). Revenue has grown at a compounded annual rate of +8% over three years and +17% over five years.
- ₹3.78 CrRevenue · FY 2025 · -13% YoY
- ₹1.19 CrNet profit · 31% margin
- ₹1.75 CrEBITDA · 46% margin
- ₹6.75 CrPaid-up capital
- +8%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sigachi Laboratories Limited are on its company page.
Detailed financial statements for Sigachi Laboratories Limited
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sigachi Laboratories Limited
Complete news archive for Sigachi Laboratories Limited
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sigachi Laboratories Limited
Sigachi Laboratories Limited is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Sigachi Laboratories Limited, Sigachi Laboratories Limited, reported revenue of ₹3.78 Cr for FY 2025, down 13% year on year.
Sigachi Laboratories Limited is primarily involved in the manufacture of bulk drugs and drug intermediates, which are essential components in the pharmaceutical industry. The companys operations are conducted from its registered office in Bonthapally and corporate office in Hyderabad, Telangana, India. Compliance with SEBI regulations is maintained through disclosures of annual reports, financial results, and corporate governance policies. Investor information, including share holding patterns and contact details of key personnel, is regularly updated and made available. The entity ensures adherence to legal standards as outlined in its CIN: L24230TG1994PLC018786, supporting ongoing activities in drug production.
Sigachi Laboratories Limited offers Bulk Drugs and Drug Intermediates.
Sigachi Laboratories Limited operates through Sigachi Laboratories Limited.
The legal entities of Sigachi Laboratories Limited currently have 9 directors, including Mohanrao Gurram, Boina Kumar, Adinarayana Tunuguntla and others.